Lupus Education Alliance Program (LEAP)

Tulane University

Status

Terminated

Conditions

COVID-19

Systemic Lupus Erythematosus

Treatments

Behavioral: LEAP Education

Behavioral: LEAP Education + Navigation

Study type

Interventional

Funder types

Other

Identifiers

NCT05243875

Pro00073870

Details and patient eligibility

About

Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).

Full description

Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).

Enrollment

274 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

18 years or older, ability to understand and speak English, diagnosis of SLE

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

274 participants in 2 patient groups

Education / Navigation

Experimental group

Description:

COVID education involving providing information about COVID for people with SLE and CDC recommendations for testing, testing options (e.g., pharmacies, doctors' offices, at-home), treatment in the event of a positive COVID result, and current recommendations around vaccination for those with SLE; and (2) navigation, which involves individual tailoring of information about where and how to get tested, and where to get vaccinated, and when appropriate, guiding participants in scheduling testing and vaccination appointments.

Treatment:

Behavioral: LEAP Education + Navigation

Education Only

Active Comparator group

Description:

Treatment:

Behavioral: LEAP Education